9 Dec 2019 09:26
HEADLINE ALTERATION
Β
The headline for the IXICO plc. announcement released on 09/12/2019 at 07:00 am under RNS No 1254W should read PDMR share sale.
Β
The announcement text is unchanged and is reproduced in full below.
Β
Β
09 December 2019
Β
IXICO plc
("IXICO" or the "Company")
Β
PDMR share sale
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 6 December 2019 that on 5 December 2019 John Hall, SVP Corporate Development and a PDMR, sold 100,000 ordinary shares at an aggregated price of 68.00p.
Β
1 Β | Details of the person discharging managerial responsibilities / person closely associated Β | ||||
a) Β | Name Β Β | John James Hall Β | |||
2 Β | Reason for the notification Β | ||||
a) Β | Position/status Β Β | PDMR (SVP Corporate Development) | |||
b) Β | Initial notification /Amendment Β Β | Initial notification | |||
3 Β | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β | ||||
a) Β | Name Β Β | IXICO plc | |||
b) Β | LEI Β Β | 2138005M1F59O6HWSA97 | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Β Β | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares in IXICO plc | |||
Identification code | GB00BCLY7L40 | ||||
Β | |||||
b) Β | Nature of the transaction Β Β | Sale | |||
c) Β | Price(s) and volume(s) | Β | Β | Β | Β |
Β | Price(s) | Volume(s) | Β | ||
Β | 68p | 100,000 | Β | ||
Β | Β | Β | Β | ||
Β | Β | Β | Β | ||
d) Β | Aggregated information | ||||
- Aggregated volume | 100,000 shares | ||||
- Price | 68p | ||||
e) Β | Date of the transaction Β Β | 5/12/19 | |||
f) Β | Place of the transaction Β Β | London Stock Exchange, AIM Market (IXI), UK | |||
Β
IXICO plc | +44 (0) 20 3763 7498 |
Giulio Cerroni, Chief Executive Officer | |
Grant Nash, Chief Financial Officer Β | |
Cenkos Securities PLC (Nominated adviser and sole broker) | +44 (0) 20 7397 8900 |
Giles Balleny / Max Gould (Corporate Finance) | |
Michael F Johnson / Russell Kerr (Sales) | |
Optimum Strategic Communications | Β +44 (0) 203 950 9144 |
Mary Clark / Supriya Mathur / Manel Mateus | |
ixico@optimumcomms.com |
Β
Follow the stocks